Satellos Bioscience Inc.
MSLE
$7.55
$0.293.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 151.33% | -75.29% | -87.32% | -92.82% | -90.81% |
| Gross Profit | -151.33% | 75.29% | 87.32% | 92.82% | 90.81% |
| SG&A Expenses | 33.02% | 19.00% | 8.66% | 2.52% | 22.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.71% | 26.80% | 17.21% | 26.94% | 78.17% |
| Operating Income | -29.71% | -26.80% | -17.21% | -26.94% | -78.17% |
| Income Before Tax | -19.71% | -4.44% | -33.56% | -37.81% | -75.42% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -20.54% | -4.98% | -34.11% | -38.21% | -75.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.54% | -4.98% | -34.11% | -38.21% | -75.42% |
| EBIT | -29.71% | -26.80% | -17.21% | -26.94% | -78.17% |
| EBITDA | -29.79% | -26.78% | -17.20% | -26.91% | -78.12% |
| EPS Basic | 20.18% | 23.86% | -9.58% | -13.90% | -33.74% |
| Normalized Basic EPS | 7.55% | 12.07% | 6.08% | 1.55% | -17.11% |
| EPS Diluted | 20.18% | 23.86% | -9.58% | -13.90% | -33.74% |
| Normalized Diluted EPS | 7.55% | 12.07% | 6.08% | 1.55% | -17.11% |
| Average Basic Shares Outstanding | 50.29% | 38.43% | 26.47% | 22.95% | 32.84% |
| Average Diluted Shares Outstanding | 50.29% | 38.43% | 26.47% | 22.95% | 32.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |